MCDONOUGH JOHN (President & CEO) sold 1.8% of their position (8.13K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $27.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2019ACC: 0000899243-19-003306
DirectorOfficer· President & CEO
Since Jul 2018
+25.20K
Net shares
Net buyer
$27.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
33.33K acquired · 8.13K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.67K
Price / share
—
Trade value
—
% of position
3.8%
2/9/2019
439.69K→456.35K
Common Stock
Direct
Shares
−8.13K
Price / share
$3.36
Trade value
$27.33K
% of position
1.8%
2/11/2019
456.35K→448.22K
Total
Net shares
+8.53K
Net value
-$27.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2019 | M · Option Exercise | +16.67K | — | — | 3.8% | 439.69K | 456.35K |
| Common Stock Direct | 2/11/2019 | S · Sale | −8.13K | $3.36 | $27.33K | 1.8% | 456.35K | 448.22K |
| Total | +8.53K | -$27.33K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
16.67K shares
Shares
+16.67K
Strike price
Held after
16.67K
Exercisable
—
2/9/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock16.67K shares | 2/9/2019 | M · Option Exercise | +16.67K | — | 16.67K |